Spotlight interview Geerten P. van Nieuw Amerongen PhD: Showing That Imatinib Protects Against Endothelial Barrier Dysfunction Via Inhibition of the Tyrosine Kinase Abl-Related Gene.

G.P. van Nieuw Amerongen

doi:10.1161/CIR.0b013e31829873ac

Spotlight interview Geerten P. van Nieuw Amerongen PhD: Showing That Imatinib Protects Against Endothelial Barrier Dysfunction Via Inhibition of the Tyrosine Kinase Abl-Related Gene.

G.P. van Nieuw Amerongen

Physiology

Research output: Contribution to journal › Article › Academic

Original language	Undefined/Unknown
Pages (from-to)	f113-f114
Journal	Circulation
Volume	127
DOIs	https://doi.org/10.1161/CIR.0b013e31829873ac
Publication status	Published - 2013

Access to Document

10.1161/CIR.0b013e31829873ac

Cite this

@article{9e46fc6591c043ae976d3d4cbea57db3,

title = "Spotlight interview Geerten P. van Nieuw Amerongen PhD: Showing That Imatinib Protects Against Endothelial Barrier Dysfunction Via Inhibition of the Tyrosine Kinase Abl-Related Gene.",

author = "{van Nieuw Amerongen}, G.P.",

year = "2013",

doi = "10.1161/CIR.0b013e31829873ac",

language = "Undefined/Unknown",

volume = "127",

pages = "f113--f114",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Spotlight interview Geerten P. van Nieuw Amerongen PhD: Showing That Imatinib Protects Against Endothelial Barrier Dysfunction Via Inhibition of the Tyrosine Kinase Abl-Related Gene.

AU - van Nieuw Amerongen, G.P.

PY - 2013

Y1 - 2013

U2 - 10.1161/CIR.0b013e31829873ac

DO - 10.1161/CIR.0b013e31829873ac

M3 - Article

VL - 127

SP - f113-f114

JO - Circulation

JF - Circulation

SN - 0009-7322

ER -